ClinicalTrials.govpublic full text
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
depression, cancer, il-2 therapy, antidepressant, immune system, neuroendocrine response, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 829168
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.